Old API Wind-down Ltd - Ordinary Shares ARLZQ

Bought more. Couldn't help myself

[snootchybootchy]

Bought more today at 4.76.  No idea why share price continues to dip down to these levels.

Things to remember:
1) no findings in the FDA inspection of the new aspirin supply facility
2) Bilastine recently approved
3) business model does not rely on buying existing drugs and boosting the price by severalfold
4) lots of cash for acquistions as other spec pharma companies look to sell assets to reduce debt

[kuatolives]

Who knows. I don't lose any sleep over trading based on nothing, it always goes in circles. Nowadays I just check my morning email to see if Yosprala has been approved, and if not, glance in a couple of times a day to check the price. ARLZ is still the most attractive of the pharmas IMO. Valeant and CXR have turned into casino plays, Merus continues to do absolutely nothing, PHM and NHC are

[kuatolives]

Picked up a few more shares this morning. Sucker for punishment :)

[snootchybootchy]

There is a rumor going around the Aralez Yahoo board that Aralez may be planning another merger, this time with QLT Inc (QLTI on the NASDAQ).  QLT is already a large Aralez shareholder.  This may explain the share price weakness.